Full Text Available
Note: Clicking the button above will open the full text document at the original institutional repository in a new window.
Heterogenous Model of Temozolomide Resistance in Glioblastoma Reveals Phenotypic Shifts in Drug Response and Migratory Potential
Saved in:
| Published in: | Advanced NanoBiomed Research |
|---|---|
| Format: | Online Article RSS Article |
| Published: |
2026
|
| Subjects: | |
| Tags: |
No Tags, Be the first to tag this record!
|
Similar Items: Heterogenous Model of Temozolomide Resistance in Glioblastoma Reveals Phenotypic Shifts in Drug Response and Migratory Potential
- Microfluidic approaches for liquid biopsy in glioblastoma: Insights into diagnostic and follow‐up strategies
- Application of Fast Integration Strategy for Multi‐Omics Data and Limited Random Forest Model in Survival Prediction of Glioblastoma
- Enabling in vivo imaging in low‐resource settings: Computed tomography imaging of gold‐loaded polymersomes for the detection of glioblastoma
- Self‐assembled verteporfin nanoparticles decrease drug efflux by P‐glycoprotein without light activation in drug‐resistant cancer cells
- Differential responses to drought in varieties of Pinus pseudostrobus sensu lato: An analysis of genetic variation and phenotypic plasticity
- Mesoporous Silica Nanoparticles With Customized Drug Ratio/Loading for Effective Treatment of Gemcitabine‐Resistant Pancreatic Tumors